RS47804A - 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba - Google Patents

1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba

Info

Publication number
RS47804A
RS47804A YU47804A YUP47804A RS47804A RS 47804 A RS47804 A RS 47804A YU 47804 A YU47804 A YU 47804A YU P47804 A YUP47804 A YU P47804A RS 47804 A RS47804 A RS 47804A
Authority
RS
Serbia
Prior art keywords
propenone
amino
methoxy
methyl
trimethoxyphenyl
Prior art date
Application number
YU47804A
Other languages
English (en)
Serbian (sr)
Inventor
Patrick Mailliet
Ceceile Combeau
Marie-Christine Bissery
Marie-Pierre Cherrier
Thomas Caulfield
Gilles Tiraboschi
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115739A external-priority patent/FR2833008B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of RS47804A publication Critical patent/RS47804A/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • C07C279/36Substituted N-nitroguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Detergent Compositions (AREA)
YU47804A 2001-12-05 2002-12-03 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba RS47804A (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115739A FR2833008B1 (fr) 2001-12-05 2001-12-05 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR0214217 2002-11-14
PCT/FR2002/004143 WO2003048106A2 (fr) 2001-12-05 2002-12-03 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
RS47804A true RS47804A (sr) 2006-12-15

Family

ID=26213287

Family Applications (1)

Application Number Title Priority Date Filing Date
YU47804A RS47804A (sr) 2001-12-05 2002-12-03 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba

Country Status (23)

Country Link
EP (1) EP1453790A2 (de)
JP (1) JP2005531494A (de)
KR (1) KR20050044712A (de)
CN (1) CN1612856A (de)
AR (1) AR037479A1 (de)
AU (1) AU2002365644A1 (de)
BR (1) BR0214694A (de)
CA (1) CA2469193A1 (de)
CO (1) CO5580759A2 (de)
EA (1) EA006803B1 (de)
HR (1) HRP20040508A2 (de)
HU (1) HUP0500100A2 (de)
IL (1) IL162223A0 (de)
MA (1) MA27351A1 (de)
MX (1) MXPA04005226A (de)
NZ (1) NZ533224A (de)
PA (1) PA8558501A1 (de)
PE (1) PE20030758A1 (de)
PL (1) PL370676A1 (de)
RS (1) RS47804A (de)
SV (1) SV2003001422A (de)
TW (1) TW200300685A (de)
WO (1) WO2003048106A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854399B1 (fr) * 2003-04-30 2006-11-17 Aventis Pharma Sa 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions les contenant et utilisation
EP1598353A1 (de) * 2004-05-17 2005-11-23 Boehringer Ingelheim International GmbH Pyrrolobenzimidazolone und ihre Verwendung als als antiproliferative Mittel
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
KR102636496B1 (ko) 2018-09-14 2024-02-15 삼성전자주식회사 통신 장치 및 이를 포함하는 전자 장치
CN109467549B (zh) * 2018-12-07 2021-02-09 中国药科大学 喹啉取代查尔酮类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904697A (en) * 1987-04-09 1990-02-27 Merrell Dow Pharmaceuticals Inc. Controlling the growth of certain tumor tissue with chalcone derivatives
JPH08277242A (ja) * 1995-02-08 1996-10-22 Kyowa Hakko Kogyo Co Ltd プロペノン誘導体
AU708925B2 (en) * 1995-12-01 1999-08-19 Kyowa Hakko Kogyo Co. Ltd. Propenone derivatives
EP0996432A2 (de) * 1997-06-26 2000-05-03 Statens Seruminstitut Biologisch-wirksame 1,3-bis-aromatische-prop-2-en-1-on, 1,3-bis-aromatische-propan-1-on, and 1,3-bis-aromatische-prop-2-yn-1-on

Also Published As

Publication number Publication date
AU2002365644A1 (en) 2003-06-17
EP1453790A2 (de) 2004-09-08
HUP0500100A2 (hu) 2005-05-30
TW200300685A (en) 2003-06-16
CO5580759A2 (es) 2005-11-30
JP2005531494A (ja) 2005-10-20
WO2003048106A2 (fr) 2003-06-12
MA27351A1 (fr) 2005-06-01
CN1612856A (zh) 2005-05-04
PE20030758A1 (es) 2003-10-07
MXPA04005226A (es) 2004-10-11
WO2003048106A3 (fr) 2004-03-25
EA200400764A1 (ru) 2004-12-30
SV2003001422A (es) 2003-07-10
EA006803B1 (ru) 2006-04-28
BR0214694A (pt) 2004-12-14
HRP20040508A2 (en) 2005-08-31
AR037479A1 (es) 2004-11-10
PL370676A1 (en) 2005-05-30
NZ533224A (en) 2006-03-31
CA2469193A1 (fr) 2003-06-12
IL162223A0 (en) 2005-11-20
PA8558501A1 (es) 2003-09-05
KR20050044712A (ko) 2005-05-12

Similar Documents

Publication Publication Date Title
KR102642823B1 (ko) 모발 성장을 조절하기 위한 조성물 및 방법
IL284397B1 (en) Compositions and methods for regulating hair growth
JPS6123183B2 (de)
CA2287565A1 (fr) Derives d'amino-acides inhibiteurs des metalloproteases de la matrice extracellulaire et de la liberation du tnf .alpha.
EP1773835B1 (de) Pyrido-pyrimidinderivate, deren herstellung und therapeutische verwendung zur behandlung von krebs
JP4780885B2 (ja) 正常細胞を化学療法剤の細胞毒性から保護するための方法
RS47804A (sr) 1,3-diarilprop-2-en-1-oni, preparati koji ih sadrže i njihova upotreba
CN108218800B (zh) 1,2,3-三氮唑类氨肽酶n抑制剂及其制备方法和应用
US20030153611A1 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing them and use thereof
CN101544669B (zh) 一种含氨基膦酸酯的苯基氰基丙烯酸酯衍生物及其制备方法和用途
CN102241665B (zh) 4-(4,5-二甲氧羰基-1,3-二硫戊环-2-基)苯甲酰-l-氨基酸苄酯及其合成方法和应用
ES2272816T3 (es) Aril-cicloalcanos sustituidos y su utilizacion como agentes anticancerigenos.
CN108047105A (zh) 3-/4-酯基取代苯甲醛缩氨基硫脲衍生物及其制备与应用
US20040229931A1 (en) 1-Aryl-3-(indol-5-yl) prop-2-en-1-ones, compositions containing them and use
CN117603226B (zh) 一种吡唑并氮氧双杂卓类化合物及其制备方法和用途
CN116730969B (zh) 一种β-拉帕醌-氨基酸缀合物及其制备方法和应用
US8404863B2 (en) Tetrahydroindoles having sphingosine-1-phosphate receptor activity
CN101735113B (zh) 一类尿素衍生物及其制法与用途
FR2833008A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
KR20040108787A (ko) 중추 신경계 장애의 치료에 사용하기 위한 실질적으로순수한 고체 형태의 3-인돌릴피브르산의 에놀 토토머
KR100916716B1 (ko) 3-클로로-5-치환-퀴녹살린-2-아민 유도체 및 약제학적으로허용 가능한 그의 염, 그의 제조방법 및 그를 유효성분으로함유하는 spc 수용체 활성으로 유발되는 염증관련 질환치료제
JP2006525291A (ja) 1−アリール−3−(インドール−5−イル)プロパ−2−エン−1−オン、該化合物を含む組成物、及びそれらの使用
CN106431855A (zh) 卤素或含氮基团取代的联苄类似物及其制备方法和用途
Młnnx et al. d'incorporation'
EP1654220A1 (de) Verbindungen zur modulierung der zellproliferation